摘要
目的:探讨经蛛网膜下腔给予单唾液酸四己糖神经节苷脂(GM-1)缓释微球保护大鼠脊髓继发性损伤的增强效应及其机制。方法:188只成年SD大鼠随机分为对照组8只,模型组60只,普通GM-1组60只和GM-1微球组60只。采用Nys- trom法制备脊髓压迫损伤模型(50g×5min),术后24,72,168和336 h检测大鼠运动功能、脑脊液中GM-1含量,术后8,24,72,168和336 h检测大鼠脊髓组织内SOD活力和MDA含量,以及脊髓Caspase-3表达情况。结果:与模型组比较,GM-1微球组大鼠BBB运动功能评分高,脑脊液中GM-1含量多,脊髓组织内SOD活力强和MDA含量少,Caspase-3表达明显,具有显著统计学差异(P<0.01),亦优于GM-1组,但无统计学差异。结论:蛛网膜下腔给予GM-1缓释微球对脊髓继发性损伤的保护作用更强,主要机制涉及抗自由基损伤和抗细胞凋亡。
To investigate the promotion effects and the protective mechanism of monosialoganglioside, GM-1 , PLGA sustained-release microspheres on secondary spinal cord injury in rats by subarachnoid medication route. Method: The one hundred and eighty-eight adult Sprague Dawley rats were randomly divided into 4 groups: control group (8 rats), model group (60 rats), normal GM-1 group (60 rats) and GM-1 microspheres group (60 rats). The spinal cord injury model (50 g×5 min) was induced by Nystroms method, the function of spinal cord was evaluated by BBB score, and the amount of GM-1 in the cerebrospinal fluid at 24, 72, 168 and 336 h after SCI were detected. The activity of SOD, the amount of MDA and the expression of Caspase-3 in spinal cord tissue at 8, 24, 72, 168 and 336 h after SCI were detected. Result: Compared with the model group, in the GM-1 microspheres group: the BBB score was higher, the amount of GM-1 in the cerebrospinal fluid was more, the amount of MDA in spinal core was less, and the activity of SOD, the expression of Caspase-3 were stronger ( P〈0.01 ). The GM-1 microspheres group was better than the normal GM- 1 group also, but it was no statistical significance. Conclusion: The protective effects of GM-1 PLGA microspheres was stronger on the secondary spinal cord injury, the mechanism included anti free radicals injury and anti apoptotic effect.
出处
《中国药师》
CAS
2007年第9期858-861,共4页
China Pharmacist